vs

Side-by-side financial comparison of BNY Mellon (BK) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.4× BNY Mellon). BNY Mellon runs the higher net margin — 108.5% vs 0.1%, a 108.5% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 12.7%). Over the past eight quarters, BNY Mellon's revenue compounded faster (13.8% CAGR vs 10.8%).

The Bank of New York Mellon Corporation, commonly known as BNY or by its prior brand name BNY Mellon, is an American international financial services company headquartered in New York City. It was established in its current form in July 2007 by the merger of the Bank of New York and Mellon Financial Corporation.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

BK vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.4× larger
CME
$1.9B
$1.3B
BK
Growing faster (revenue YoY)
CME
CME
+1.7% gap
CME
14.5%
12.7%
BK
Higher net margin
BK
BK
108.5% more per $
BK
108.5%
0.1%
CME
Faster 2-yr revenue CAGR
BK
BK
Annualised
BK
13.8%
10.8%
CME

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BK
BK
CME
CME
Revenue
$1.3B
$1.9B
Net Profit
$1.5B
$1.2M
Gross Margin
Operating Margin
0.1%
Net Margin
108.5%
0.1%
Revenue YoY
12.7%
14.5%
Net Profit YoY
26.5%
20.7%
EPS (diluted)
$2.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BK
BK
CME
CME
Q1 26
$1.9B
Q4 25
$1.3B
$1.6B
Q3 25
$1.2B
$1.5B
Q2 25
$1.2B
$1.7B
Q1 25
$1.2B
$1.6B
Q4 24
$1.2B
$1.5B
Q3 24
$1.0B
$1.6B
Q2 24
$1.0B
$1.5B
Net Profit
BK
BK
CME
CME
Q1 26
$1.2M
Q4 25
$1.5B
$1.2B
Q3 25
$1.4B
$908.0M
Q2 25
$1.4B
$1.0B
Q1 25
$1.2B
$956.2M
Q4 24
$1.2B
$874.6M
Q3 24
$1.2B
$912.8M
Q2 24
$1.2B
$883.2M
Operating Margin
BK
BK
CME
CME
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
BK
BK
CME
CME
Q1 26
0.1%
Q4 25
108.5%
71.7%
Q3 25
116.9%
59.1%
Q2 25
118.3%
60.6%
Q1 25
105.3%
58.2%
Q4 24
96.7%
57.3%
Q3 24
112.8%
57.6%
Q2 24
113.4%
57.6%
EPS (diluted)
BK
BK
CME
CME
Q1 26
Q4 25
$2.01
$3.24
Q3 25
$1.88
$2.49
Q2 25
$1.93
$2.81
Q1 25
$1.58
$2.62
Q4 24
$1.53
$2.40
Q3 24
$1.50
$2.50
Q2 24
$1.52
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BK
BK
CME
CME
Cash + ST InvestmentsLiquidity on hand
$5.1B
$2.4B
Total DebtLower is stronger
$31.9B
$3.4B
Stockholders' EquityBook value
$44.3B
Total Assets
$472.3B
$202.0B
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BK
BK
CME
CME
Q1 26
$2.4B
Q4 25
$5.1B
$4.5B
Q3 25
$5.1B
$2.6B
Q2 25
$5.7B
$2.1B
Q1 25
$5.4B
$1.5B
Q4 24
$4.2B
$3.0B
Q3 24
$6.2B
$2.4B
Q2 24
$5.3B
$1.9B
Total Debt
BK
BK
CME
CME
Q1 26
$3.4B
Q4 25
$31.9B
Q3 25
$32.3B
Q2 25
$33.4B
Q1 25
$30.9B
Q4 24
$30.9B
Q3 24
$33.2B
Q2 24
$30.9B
Stockholders' Equity
BK
BK
CME
CME
Q1 26
Q4 25
$44.3B
$28.7B
Q3 25
$43.9B
$28.2B
Q2 25
$44.0B
$27.7B
Q1 25
$43.1B
$27.0B
Q4 24
$41.3B
$26.5B
Q3 24
$42.0B
$28.2B
Q2 24
$40.8B
$27.6B
Total Assets
BK
BK
CME
CME
Q1 26
$202.0B
Q4 25
$472.3B
$198.4B
Q3 25
$455.3B
$187.1B
Q2 25
$485.8B
$179.9B
Q1 25
$440.7B
$157.8B
Q4 24
$416.1B
$137.4B
Q3 24
$427.5B
$137.8B
Q2 24
$428.5B
$123.4B
Debt / Equity
BK
BK
CME
CME
Q1 26
Q4 25
0.72×
Q3 25
0.74×
Q2 25
0.76×
Q1 25
0.72×
Q4 24
0.75×
Q3 24
0.79×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BK
BK
CME
CME
Operating Cash FlowLast quarter
$5.2B
Free Cash FlowOCF − Capex
$4.7B
FCF MarginFCF / Revenue
352.8%
Capex IntensityCapex / Revenue
32.4%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$5.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BK
BK
CME
CME
Q1 26
Q4 25
$5.2B
$1.1B
Q3 25
$-1.1B
$968.1M
Q2 25
$2.2B
$1.1B
Q1 25
$412.0M
$1.1B
Q4 24
$1.6B
$1.0B
Q3 24
$-312.0M
$1.0B
Q2 24
$2.1B
$776.9M
Free Cash Flow
BK
BK
CME
CME
Q1 26
Q4 25
$4.7B
$1.1B
Q3 25
$-1.5B
$949.7M
Q2 25
$1.8B
$1.0B
Q1 25
$92.0M
$1.1B
Q4 24
$1.1B
$991.7M
Q3 24
$-687.0M
$973.2M
Q2 24
$1.7B
$758.7M
FCF Margin
BK
BK
CME
CME
Q1 26
Q4 25
352.8%
66.8%
Q3 25
-121.5%
61.8%
Q2 25
152.8%
61.5%
Q1 25
7.9%
67.1%
Q4 24
95.2%
65.0%
Q3 24
-65.6%
61.4%
Q2 24
169.6%
49.5%
Capex Intensity
BK
BK
CME
CME
Q1 26
Q4 25
32.4%
2.0%
Q3 25
35.4%
1.2%
Q2 25
29.8%
1.1%
Q1 25
27.6%
0.9%
Q4 24
34.6%
1.7%
Q3 24
35.8%
1.9%
Q2 24
37.1%
1.2%
Cash Conversion
BK
BK
CME
CME
Q1 26
Q4 25
3.55×
0.96×
Q3 25
-0.74×
1.07×
Q2 25
1.54×
1.03×
Q1 25
0.34×
1.17×
Q4 24
1.34×
1.16×
Q3 24
-0.26×
1.10×
Q2 24
1.82×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons